ETFs Holding AKAO »    AKAO Historical Stock Prices »
AKAO News Video: Mon, Aug 20, 2018, 1:34 PM — Monday Sector Laggards: Biotechnology, Drugs

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Achaogen is a biopharmaceutical company engaged in discovering, developing, and commercializing antibacterial treatments against multi-drug resistant (MDR) gram-negative infections. Co. develops plazomicin for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. Co. also develops antibacterial candidate, C-Scape, an orally-administered combination of ceftibuten and clavulanate for oral treatment for patients with cUTI, and acute pyelonephritis, caused by expanded spectrum beta-lactamases-producing Enterobacteriaceae. Self directed investors in Achaogen, Inc will be interested in keeping up with all Achaogen, Inc news they can find, both AKAO news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on AKAO. At RediNews, we simplify this task by presenting both AKAO news releases originating from Achaogen, Inc itself, and AKAO news from a variety of media outlets. Visitors can browse this news online and through our AKAO RSS news feed.


AKAO News — Articles, Videos, & Press Releases

Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%
Tuesday, April 16, 2019, 5:17 PM — Zacks
Peek Under The Hood: IWO Has 33% Upside
Wednesday, November 7, 2018, 7:53 AM — ETF Channel
Notable Monday Option Activity: AKAO, NAV, ABMD
Monday, November 5, 2018, 3:22 PM — Stock Options Channel
Short Interest Falls 17.2% For AKAO
Wednesday, October 10, 2018, 2:05 PM — Market News Video
Surprising Analyst 12-Month Target For SPSM
Wednesday, October 3, 2018, 7:28 AM — ETF Channel
Interesting AKAO Call Options For November 16th
Thursday, September 27, 2018, 10:46 AM — Stock Options Channel
Achaogen Becomes Oversold (AKAO)
Wednesday, September 12, 2018, 4:25 PM — Dividend Channel
We Did The Math IWO Can Go To $241
Thursday, August 30, 2018, 7:23 AM — ETF Channel
Achaogen Becomes Oversold (AKAO)
Tuesday, August 7, 2018, 12:03 PM — Dividend Channel
Analysts Forecast 10% Gains Ahead For PBSM
Monday, July 30, 2018, 8:32 AM — ETF Channel
First Week of March 2019 Options Trading For Achaogen (AKAO)
Wednesday, July 25, 2018, 10:48 AM — Stock Options Channel
Analysts Anticipate PBSM To Hit $32
Thursday, June 28, 2018, 8:31 AM — ETF Channel
Achaogen Enters Oversold Territory (AKAO)
Tuesday, June 26, 2018, 11:53 AM — Dividend Channel
First Week of AKAO August 17th Options Trading
Thursday, June 21, 2018, 10:48 AM — Stock Options Channel
Noteworthy Wednesday Option Activity: WBA, AKAO, XENT
Wednesday, June 20, 2018, 3:33 PM — Stock Options Channel
Bullish Two Hundred Day Moving Average Cross - AKAO
Wednesday, June 20, 2018, 11:49 AM — Market News Video
First Week of AKAO July 20th Options Trading
Tuesday, May 22, 2018, 11:14 AM — Stock Options Channel
AKAO is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

GEN News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AKAO News | | Copyright © 2013 - 2019, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.